NGM Biopharmaceuticals Inc (NGM)
NASDAQ:NGM
Holding NGM?
Track your performance easily

NGM Biopharmaceuticals (NGM) Balance Sheet

330 Followers

NGM Biopharmaceuticals Balance Sheet

NGM Biopharmaceuticals's total assets for Q3 2023 were $192.15M, a decrease of -12.58% from the previous quarter. NGM total liabilities were $22.34M for the fiscal quarter, a -21.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 307.40M$ 402.39M$ 329.04M$ 380.40M$ 246.09M
Total Liabilities
$ 47.84M$ 66.74M$ 49.00M$ 49.68M$ 354.28M
Total Equity Gross Minority
$ 259.59M$ 335.65M$ 280.04M$ 330.72M$ -108.20M
Total Capitalization
$ 259.56M$ 335.65M$ 280.04M$ 330.72M$ -108.20M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 0.00--
Currency in USD

NGM Biopharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis